Last reviewed · How we verify
Metastatic Breast Cancer
Approved treatments
- Doxorubicin Hydrochloride · Pfizer Inc.
Doxorubicin intercalates nucleotide bases and interacts with topoisomerase II to form DNA-cleavable complexes, inhibiting DNA/RNA replication.
Pipeline
- Palbociclib + aromatase inhibitor · Pfizer Inc. — preclinical
- Letrozole 2.5mg · Pfizer Inc. — preclinical
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Metastatic Breast Cancer patent landscape — cliff calendar, originator estates, attackable patents
- Metastatic Breast Cancer treatment landscape brief
- Metastatic Breast Cancer treatment updates RSS
Frequently asked questions about Metastatic Breast Cancer
What drugs treat Metastatic Breast Cancer?
Tracked treatments include Doxorubicin Hydrochloride.
What is the treatment for Metastatic Breast Cancer?
Standard treatment for Metastatic Breast Cancer includes Doxorubicin Hydrochloride. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Metastatic Breast Cancer?
2 pipeline drugs tracked. Top candidates: Palbociclib + aromatase inhibitor, Letrozole 2.5mg.
Related
- Treatment landscape: Metastatic Breast Cancer patent cliff · Metastatic Breast Cancer CI report
- Treatment: Doxorubicin Hydrochloride · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing